Stay updated on Avelumab/Axitinib vs Sunitinib in Advanced Renal Cell Cancer Clinical Trial
Sign up to get notified when there's something new on the Avelumab/Axitinib vs Sunitinib in Advanced Renal Cell Cancer Clinical Trial page.

Latest updates to the Avelumab/Axitinib vs Sunitinib in Advanced Renal Cell Cancer Clinical Trial page
- Check2 days agoChange DetectedThe page has been updated to version v2.16.5, and the previous version v2.16.4 has been removed from the content. Additionally, a significant note regarding the modernization of ClinicalTrials.gov data ingest scheduled for July 2025 has been deleted.SummaryDifference0.3%
- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedThe expected modernization date for the ClinicalTrials.gov data ingest has been pushed back from June 2025 to July 2025.SummaryDifference0.3%
- Check24 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.0%
- Check31 days agoNo Change Detected
- Check38 days agoChange DetectedThe web page has been updated to indicate that the ClinicalTrials.gov data ingest will be modernized in June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.SummaryDifference0.4%
- Check45 days agoChange DetectedThe page has removed a citation regarding the efficacy of avelumab plus axitinib in treating sarcomatoid renal cell carcinoma, which included details about a clinical trial and its publication.SummaryDifference0.1%
- Check67 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.0%
Stay in the know with updates to Avelumab/Axitinib vs Sunitinib in Advanced Renal Cell Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Avelumab/Axitinib vs Sunitinib in Advanced Renal Cell Cancer Clinical Trial page.